Sun Pharmaceutical to adopt a ‘disciplined’ approach to M&A: Dilip Shanghvi

February 1, 2026

Asked about the strategic priorities in the US, he added: “Not only the US, but we have interest in selling innovative medicines globally… for emerging markets we are looking at tuck-ins or smaller acquisitions which we can look at integrating with our existing business to get scale in the emerging markets.” Shanghvi added.

More To Explore

India defies West Asia war concerns as Q4 GDP growth hits 7.8%; risks remain ahead

India’s economy surged by a better-than-expected 7.8% in the March quarter, exceeding forecasts and pushing FY26 growth to 7.7%. This robust performance was driven by

June 6, 2026

Central bank turns piper to draw in foreign capital; leaves repo rate at 5.25, keeps stance neutral

The Reserve Bank of India has introduced measures to boost foreign currency inflows, including incentives for external commercial borrowings and bearing hedging costs on FCNR(B)

June 6, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003